Order Article Reprints

Tsai M-C, Huang C-C, Wei Y-C, Liu T-T, Lin M-T, Yi L-N, Lin P-R, Wang C-C, Chu T-H, Hsiao C-C, et al. Combined Chibby and β-Catenin Predicts Clinical Outcomes in Patients with Hepatocellular Carcinoma. International Journal of Molecular Sciences. 2020; 21(6):2060. https://doi.org/10.3390/ijms21062060

Tsai, Ming-Chao, Chao-Cheng Huang, Yu-Ching Wei, Ting-Ting Liu, Ming-Tsung Lin, Li-Na Yi, Pey-Ru Lin, Chih-Chi Wang, Tian-Huei Chu, Chang-Chun Hsiao, and et al. 2020. "Combined Chibby and β-Catenin Predicts Clinical Outcomes in Patients with Hepatocellular Carcinoma" International Journal of Molecular Sciences 21, no. 6: 2060. https://doi.org/10.3390/ijms21062060

Tsai, M. -C., Huang, C. -C., Wei, Y. -C., Liu, T. -T., Lin, M. -T., Yi, L. -N., Lin, P. -R., Wang, C. -C., Chu, T. -H., Hsiao, C. -C., Hu, T. -H., & Tai, M. -H. (2020). Combined Chibby and β-Catenin Predicts Clinical Outcomes in Patients with Hepatocellular Carcinoma. International Journal of Molecular Sciences, 21(6), 2060. https://doi.org/10.3390/ijms21062060